Product Program year 2020 Source: CMS Open Payments

V160

Biological Vaccine

Open in the dashboard

General payments

$58,862

53 payments

Research payments

$10,205,154

8,161 payments

Through program year 2020, $58,862 in general payments and $10,205,154 in research payments were reported against V160 (Vaccine).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $11,799 18
2020 Research $3,624,524 3,104
2019 General $47,063 35
2019 Research $6,580,630 5,057

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $58,862 53 payments
Top recipients General payments · program year 2020
  1. Anna Wald Infectious Disease · Seattle, WA $5,993 51% · 5 payments
  2. Kawsar Talaat Infectious Disease · Baltimore, MD $3,319 28% · 7 payments
  3. Suresh Boppana Pediatrics · Birmingham, AL $850 7% · 2 payments
  4. Stuart Adler Pediatric Infectious Diseases · Richmond, VA $750 6% · 2 payments
  5. David Bernstein Pediatric Infectious Diseases · Cincinnati, OH $638 5% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Infectious Disease Internal Medicine $9,311 79% · 2 practitioners
  2. Pediatric Infectious Diseases Pediatrics $1,388 12% · 2 practitioners
  3. Pediatrics $850 7% · 1 practitioner
  4. Maternal & Fetal Medicine Obstetrics & Gynecology $250 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Washington $5,993 51% · 1 recipient
  2. Maryland $3,319 28% · 1 recipient
  3. Alabama $850 7% · 1 recipient
  4. Virginia $750 6% · 1 recipient
  5. Ohio $638 5% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

53 general · 8,161 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record